Clinical Survey of Oticon Medical Ponto BHX Implant
Launched by OTICON MEDICAL · Sep 18, 2017
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients eligible for treatment with a bone anchored hearing aid
- • 18 years or older
- Exclusion Criteria:
- • Inability to participate in follow-up
- • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
About Oticon Medical
Oticon Medical is a leading global innovator in the field of hearing solutions, dedicated to improving the quality of life for individuals with hearing loss. As a subsidiary of the well-established Oticon brand, Oticon Medical specializes in the development and manufacture of advanced auditory devices, including bone-anchored hearing systems and implantable solutions. Committed to research and development, the company actively sponsors clinical trials to evaluate the efficacy and safety of its products, ensuring that cutting-edge technology continues to meet the evolving needs of patients and healthcare professionals. With a focus on evidence-based practices, Oticon Medical strives to enhance auditory experiences and foster better communication for those affected by hearing impairment.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hellerup, Copenhagen, Denmark
Aalborg, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials